He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652]
Corresponding Author of This Article
Dan Wang, PhD, Professor, College of Basic Medicine, Beihua University, No. 3999 Binjiangdonglu, Jilin 132013, Jilin Province, China. jljl1215@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
He QJ, Li YF, Zhao LT, Lin CT, Yu CY, Wang D. Recent advances in age-related metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(7): 652-662 [PMID: 38515956 DOI: 10.3748/wjg.v30.i7.652]
World J Gastroenterol. Feb 21, 2024; 30(7): 652-662 Published online Feb 21, 2024. doi: 10.3748/wjg.v30.i7.652
Recent advances in age-related metabolic dysfunction-associated steatotic liver disease
Qian-Jun He, Yi-Fei Li, Ling-Tong Zhao, Chun-Tong Lin, Chun-Yan Yu, Dan Wang
Qian-Jun He, Ling-Tong Zhao, Chun-Tong Lin, Chun-Yan Yu, Dan Wang, College of Basic Medicine, Beihua University, Jilin 132013, Jilin Province, China
Yi-Fei Li, Department of Traumatic Surgery, Jilin Central Hospital, Jilin 132001, Jilin Province, China
Author contributions: All authors performed the literature review and wrote the manuscript; He QJ drew and modified the illustrations; Li YF, Yu CY, and Wang D critically reviewed and revised the manuscript.
Supported byJilin Provincial Department of science and Technology, No. YDZJ202301ZYTS112 and No. YDZJ202101ZYTS090; and Jilin Provincial Health and Family Planning Commission, No. 2021JC084.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Dan Wang, PhD, Professor, College of Basic Medicine, Beihua University, No. 3999 Binjiangdonglu, Jilin 132013, Jilin Province, China. jljl1215@163.com
Received: November 12, 2023 Peer-review started: November 12, 2023 First decision: December 25, 2023 Revised: December 30, 2023 Accepted: January 22, 2024 Article in press: January 22, 2024 Published online: February 21, 2024 Processing time: 101 Days and 3.9 Hours
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of the world's population and has become a leading cause of chronic liver disease. In recent years, an increasing amount of data suggests that MASLD is associated with aging. As the population ages, age-related MASLD will become a major global health problem. Targeting an aging will become a new approach to the treatment of MASLD. This paper reviews the current studies on the role of aging-related factors and therapeutic targets in MASLD, including: Oxidative stress, autophagy, mitochondrial homeostasis, bile acid metabolism homeostasis, and dysbiosis. The aim is to identify effective therapeutic targets for age-related MASLD and its progression.
Core Tip: Aging is closely associated with metabolic dysfunction-associated steatotic liver disease (MASLD). We will focus on the main features of age-related MASLD, the mechanisms by which age-related factors, such as oxidative stress, autophagy, mitochondrial homeostasis, bile acid metabolism and bacterial dysbiosis induce MASLD, as well as the study of related therapeutic targets.
